HealthyDirect · GrowthFit for a long SIP
Invesco India Manufacturing Fund
Invesco Mutual FundEquity Schemes - Thematic Fund2.2 years
The scheme seeks to generate capital appreciation from a diversified portfolio of Equity and Equity Related Instruments of companies following the manufacturing theme.
- NAV
- 11.74
- 29 Oct 2026
- 1Y
- +12.1%
- Trailing CAGR
- AUM
- ₹732.2 Cr
- 30 Sept 2026
- Volatility
- High
- 17.0% annualized
Buying brief
Should you add this fund?
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
In three lines
Fits if · The fund beat the category median in 71% of rolling 1-year windows.
Buy checklist
History depth
Fail
2.2 years - thin for judging consistency.
Engine status
Pass
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Expense ratio
Pass
1.15% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -21.6%. Ask whether you can hold through a similar fall.
Vs category
n/a
Category relative read still thin.
Manager tenure
Watch
Nikhil Kale · 0.9 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 37.2% of the portfolio.
Evidence supports a shortlist - confirm with peers before you buy elsewhere.
Before you buy or SIP
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 22%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
If you start a SIP here, diary a 90-day check and an annual review - don’t react to every NAV print.
NAV
Path not in current snapshots
n/a
Returns
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
- 1Y+12.1%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- SI+7.2%
SIP XIRR
Equal monthly instalments to latest NAV
- 1Y+19.3%
- 3Yn/a
- 5Yn/a
- 10Yn/a
- Since inception
- +7.2%
- Calendar-day CAGR
- Excess 1Y
- +16.7%
- Category median, same plan and option
- 3Y win rate
- n/a
- Windows beating the median
- 3Y percentile
- n/a
- Vs comparable share classes
- SIP 3Y XIRR
- n/a
- Simulated monthly SIP
- Worst rolling 3Y
- n/a
- 0 daily-ending windows
- Median rolling 3Y
- n/a
- Calendar-day CAGR
- Positive rolling 5Y
- n/a
- 0 daily-ending windows
Drawdown
Peak to trough from a running NAV high, with the path and recovery episodes.
- Max drawdown
- -21.6%
- Worst peak-to-trough
- Current
- -5.2%
- Below last peak
- Current spell
- 70 days
- Days below latest peak
- Time below peak
- +91%
- NAV observations
Drawdown
Path not in current snapshots
n/a
- Average recovery
- 30 days
- 18 recovered episodes
- Longest recovery
- 433 days
- Trough to prior peak
2 Jan 2025 – 7 May 2026
Trough 28 Feb 2025 · recovered in 433 days
-21.6%
20 Aug 2026 – open
Trough 23 Oct 2026 · not recovered
-9.2%
15 Oct 2024 – 2 Jan 2025
Trough 13 Nov 2024 · recovered in 50 days
-8.3%
27 Sept 2024 – 14 Oct 2024
Trough 7 Oct 2024 · recovered in 7 days
-5.1%
Dimensions
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
49
Vs category
100
Consistency
71
Risk-adjusted
33
Drawdown
46
Mean
60
Decision
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Healthy
Buying stance
Fit for a long SIP
Evidence supports keeping this on a shortlist for a multi-year equity SIP.
Why this status
- No material deterioration, cost shock, or persistent category underperformance in the current evidence set.
Supporting reads
- The fund beat the category median in 71% of rolling 1-year windows.
Portfolio
30 Sept 2026 · 47 holdings · top 10 are 37.2%.
- Top 5
- 21.5%
- Top 10
- 37.2%
- Largest holding
- 6.6%
- Effective holdings
- 37.1
Net Receivables
Unspecified
6.6%
SEDEMAC Mechatronics Ltd.
Industrials
4.0%
Divi's Laboratories Ltd
Healthcare
3.9%
TVS Motor Company Ltd
Consumer Discretionary
3.6%
INDO-MIM Ltd.
Industrials
3.5%
What changed
DECISION
Status moved from MONITOR to HEALTHY.
16 Oct 2026
Worth investigating
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
Mahindra Manulife Business Cycle Fund
Mahindra Manulife Mutual Fund
- 1Y
- -3.8%
- 3Y
- +16.3%
- Vol
- 15.7%
- Max DD
- -21.4%
- Sharpe
- 0.58
- 3Y win
- +100%
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
- Lower TER
- Higher trailing returns
360 ONE QUANT FUND
360 ONE Mutual Fund
- 1Y
- -8.9%
- 3Y
- +13.5%
- Vol
- 16.6%
- Max DD
- -22.4%
- Sharpe
- 0.56
- 3Y win
- +91%
- Lower volatility
- Higher win rate vs category
- Lower TER
- Higher trailing returns
Caveat: Deeper drawdown
HSBC India Export Opportunities Fund
HSBC Mutual Fund
- 1Y
- +13.7%
- 3Y
- n/a
- Vol
- 16.1%
- Max DD
- -20.5%
- Sharpe
- 0.17
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Lower TER
- Higher trailing returns
Nippon India Active Momentum Fund
Nippon India Mutual Fund
- 1Y
- +1.6%
- 3Y
- n/a
- Vol
- 15.2%
- Max DD
- -12.6%
- Sharpe
- 0.53
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns
WhiteOak Capital Special Opportunities Fund
WhiteOak Capital Mutual Fund
- 1Y
- +7.2%
- 3Y
- n/a
- Vol
- 14.7%
- Max DD
- -17.0%
- Sharpe
- 0.67
- 3Y win
- n/a
- Lower volatility
- Shallower drawdown
- Higher win rate vs category
Caveat: Higher TER · Lower trailing returns